Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nesiritide for Renal Protection in Cardiovascular Surgery
NCT01440881Phase 2Completed
- Sponsor
- University of Florida
- Start
- Apr 2010
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nesiritide in acute kidney injury (AKI), sponsored by University of Florida. Primary endpoints: Neutrophil Count for Kidney Injury at 30 days and Cytokine Levels for Kidney Injury at 30 days. Started Apr 2010; status: completed.
02
Drugs
nesiritide
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT01440881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01440881.